A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma
| Title: | A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma |
|---|---|
| Authors: | Lam, Wei-Sen, Creaney, Jenette, Chen, Fred K., Chin, Wee Loong, Muruganandan, Sanjeevan, Arunachalam, Sukanya, Attia, Mary S., Read, Catherine, Murray, Kevin, Millward, Michael, Spiro, Jon, Chakera, Aron, Gary Lee, Y.C., Nowak, Anna K. * |
| Source: | In Lung Cancer February 2020 140:87-92 |
| Database: | ScienceDirect |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2019.12.018 |
| Published in: | Lung Cancer |
| Language: | English |